Streptococcus pneumoniae type 17f capsular polysaccharide antigen Recruiting Phase 2 Trials for Asplenia Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02232191Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients